Life science & Health

During the NBI Expo new innovations and cooperations are sought within the Lifescience & Health sector by participating countries. New biological resources and research & development programs are offered at the different country investment presentations, as well as the round tabel sessions for the development of innovative cooperation and business acquisition.

General Sector Information
The sector encompasses pharmaceuticals, health care, biotech and the medical diagnostics sub sectors that focus on health quality.
Following years of growth and favorable market trends, the global life sciences industry now finds itself facing a challenging "new normal."

A changing health care landscape, expiring patents and generic competition, pricing pressures, heightened regulatory scrutiny, expansion into emerging markets, increasing alliances and acquisitions, and a persistent economic slowdown are prompting global life sciences companies to adopt new business models designed to counter slowing sales growth and declining profitability, deliver better patient outcomes at lower cost, and position them for success in 2013 and beyond.

To grow in this challenging climate, the global life sciences industry is transitioning away from a primary-care, small-molecule-driven sales model towards targeting specialist secondary care indications through the use of high-value biologic therapies in the developed markets (Europe and the U.S.), while also taking a global perspective by marketing branded and off-patent medicines in the fast-growing emerging markets. 

PROGRAM LIFE SCIENCE & HEALTH

Different countries are promoting their life science and health sectors during the NBI Expo.
Please visit their stand or make an appointment with these representatives through the online registration and matchmaking system.

Some concrete examples: